Follow-The-Filings

Security

AXSM

Axsome Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

14 owners 1 new max 0.5% (Torray Investment Partner...)

grid → activity →
owners 14
max % 0.5%
tracked value $1.2B
qoq N 1 A 6 R 4

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Torray Investment Partners LLC 2026 Q2 stale 0.5% Add +0.13 pp 14,928 $4M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.1% Add +0.09 pp 424,750 $72M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.1% Add +0.01 pp 603,465 $102M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 164,300 $28M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit -0.04 pp 145,597 $27M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% Add +0.01 pp 56,951 $10M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce -0.03 pp 141,236 $24M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 4,164,818 $761M hist
Norges Bank 2025 Q4 stale 0.0% Exit -0.01 pp 495,456 $90M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 281,503 $48M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 104,059 $18M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 20,758 $4M hist
Farallon Capital Management LLC 2026 Q1 0.0% — 4,000 $676 hist
Polen Capital Management LLC 2026 Q1 0.0% New 0.0% 2,116 $358 hist

14 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $270.6M $385.69M $638.5M
Gross profit — — —
Gross margin — — —
Net income -$239.24M -$287.22M -$183.17M
Net margin * -88.4% -74.5% -28.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $504.26M $485.06M $588.99M
Total non-current assets * $83.97M $83.43M $100.82M
Total assets $588.24M $568.5M $689.8M
Total current liabilities $138.85M $230.1M $378.84M
Total non-current liabilities * $258.4M $281.38M $222.67M
Total equity $190.98M $57.02M $88.3M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$145.08M -$128.41M -$93.4M
Cash from investing -$582,000 -$270,000 -$480,000
Cash from financing $331.01M $57.84M $101.46M
Net change in cash $185.35M -$70.84M $7.58M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders